These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1414697)

  • 41. An Alternative to Topical Dosing to Deliver Drugs to Target Tissues.
    Waterbury LD
    J Ocul Pharmacol Ther; 2017; 33(1):3-4. PubMed ID: 27923107
    [No Abstract]   [Full Text] [Related]  

  • 42. The mydriatic effect of tropicamide on light and dark irides.
    Dillon JR; Tyhurst CW; Yolton RL
    J Am Optom Assoc; 1977 May; 48(5):653-8. PubMed ID: 893935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of three madriatics on the human ocular aberrations].
    Yu J; Chen H; Hu JY; Xun PC
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):826-31. PubMed ID: 16191351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) versus tropicamide (0.5 or 1.0%) as a function of iris and skin pigmentation, and age.
    Cooper J; Feldman JM; Jaanus SD; Appleman W; Appel S; Horn D
    J Am Optom Assoc; 1996 Nov; 67(11):669-75. PubMed ID: 8979660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neurotransmitter control of pupillary motoricity in man].
    De Marinis M; Barbieri RM; Grillo G; Feliciani M; Agnoli A
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2353-8. PubMed ID: 6152173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Aqueous flare and cells after mydriasis in normal human eyes].
    Oshika T; Kato S; Inamochi K; Mori M; Araie M
    Nippon Ganka Gakkai Zasshi; 1989 Jun; 93(6):698-704. PubMed ID: 2816578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of topical 1% tropicamide on Schirmer tear test results in clinically normal horses.
    Selk Ghaffari M; Sabzevari A; Radmehr B
    Vet Ophthalmol; 2009; 12(6):369-71. PubMed ID: 19883467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraocular pressure change following application of 1% tropicamide for diagnostic mydriasis.
    Pukrushpan P; Tulvatana W; Kulvichit K
    Acta Ophthalmol Scand; 2006 Apr; 84(2):268-70. PubMed ID: 16637852
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should the pupil be used as a fixed reference for instrument alignment?
    Schachar RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2040-1. PubMed ID: 16412898
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats.
    Schmidt KS; Hacker DV; Kass PH; Barkhoodarian AL
    Vet Ophthalmol; 2006; 9(2):137-9. PubMed ID: 16497239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes of higher-order aberrations with the use of various mydriatics.
    Kim JH; Lim T; Kim MJ; Tchah H
    Ophthalmic Physiol Opt; 2009 Nov; 29(6):602-5. PubMed ID: 19663926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
    Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A clinical comparison of mydriatics.
    Molinari JF
    J Am Optom Assoc; 1983 Sep; 54(9):781-4. PubMed ID: 6619480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of drugs in ointment for routine mydriasis.
    Hendrickson RO; Hanna C
    Ann Ophthalmol; 1977 Mar; 9(3):333-6. PubMed ID: 869415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomised controlled single-blind study of conventional versus depot mydriatic drug delivery prior to cataract surgery.
    Dubois V; Wittles N; Lamont M; Madge S; Luck J
    BMC Ophthalmol; 2006 Nov; 6():36. PubMed ID: 17129389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits.
    Nomura T; Imai T; Otagiri M
    Biol Pharm Bull; 1993 Mar; 16(3):298-303. PubMed ID: 8364476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of mydriatics and a miotic on ocular discomfort and pupil responses.
    King VM
    J Am Optom Assoc; 1976 Jul; 47(7):937-42. PubMed ID: 1030718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects on pupil size and accommodation of sympathetic and parasympatholytic agents.
    Paggiarino DA; Brancato LJ; Newton RE
    Ann Ophthalmol; 1993 Jul; 25(7):244-9, 253. PubMed ID: 8363290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.